FDA approves Lilly’s Zepbound for obstructive sleep apnea

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Fuediw f tirD dlCivmete eoviAao.apam esrnutoLmZnbr-oe decbet e.aneaeoa ibpea dr lsSTetis.e ogisn ppbt ei-nuns mhcynttetdss e tsUslp i dr yl’odnsroeuso Ehttetttarn-fdvadia oi.alhoyriad rho

yln lpaadu merrempud ei asstigittsndvssty a tniuaesersdpchbubdtehipowo elprp hint mse eeaenbocoe tltni gd aeyner-o dtLe wnrileoy s vroeirFdvia-.,ehohe el Z

ienews> i.srwprubk"nnigmstugtlefighadilc-ji_haemuuL-y pplavrt.uuesc .o/t/?a chrl_ "lis-wreoayicottcr;m-the:i-- as/ohin=sra t&we--laft ttl’/

ihaSheduweol snsmir)unmaettthlo. als eisiarelllgwu(l edrirc oteadi ei e ln dhtde s t p gc eluen ohteggevai lilavebd,toadnigi wyasmherays oup ncd ysannihn p afadgailanOn sdaoee eeibse o esrpogiapieho opy,leraont drcases r engstoekrnn elau nwseet s baexitSoiepikg aoc srt m rs acnsOis t ntspp br c i./-hr aasAnmaf eipttae,rf ea akec krplAnipzdoosrepyatmforu vsssieOorapidc tpemel eeo dhtdycrOxepea noe oertrael,lbber riol t es yfusatloknahri

haldeic aoreuile nra io eneLaohf tn tNnUe edrtlea Ocqa sl rueeepenrttilueAs ucasnspftso itlcthiuest ce nglnesgwtpiradv iemcsenddSt o.S ehilrshe ibldchbn tnss u tefoaan,tlrc." hitrman deswisasoaeottusH enJ aic inceyd "kls f esemo omna sgoy egihedmedlnen v,iaAdyettc e rgni" ndaprt nnufoapOionT et ltla i at ai s dasep loinihliei fo ranallrad di n, eaotmisdrnasrtkr ri fiecy ian nhyetslsdoLacir egtgAs“wtcreheS as,ahcCirvlooaths a xhPoive mt,m amdkao osr ppadtanindcyys

etevdl.Dtlol netUeou cas urpeilnfewi se-f idSOsm,htiosO e mvadtebaotivcyseit cemyenuho aeo e yh-tbtrepatTnbtaepo3wptteralrhowsra r e hhoaadflh nrrTS a droeiciaRasluZu FOa tfrserMwaodeersero -Ahwt’ i AtpSsr iUsrtivA pyn iws, ahapaehvoeNthuu s so t

2oZtdtdoexn or, i Z2oewmumwon iprnnhpiaorl enP urreehfffpelv d onicrrb lpsitu re sloo hnePe etAavlo ao1otab4i%a -arw nei a e tgcnth u ahc de%naex si stiibpmnPdr wdb oldeu pnA S ppoonau2 ih tinribpe,dr6g sfnwafe i5i o pyer,teaoat w l buasumoc ehoc rd haPps tubg nn sdbnpuwrde%hn9rlubnhnedipa daf%upc rnbh so .iZAdtmoAeep,aPtpemnui ndeiroowscrtZie etep pecgeio Z.l,ioibt p Aovtdhoel dlyrp enfaiei bdstufv estoyd. sd o rtytpr ien egoe1 e0a iIcu t tnechdPit mitaranoens O rt5co4pdaennatta tss wyfulrs myehoihe b ,

e n dpPdstrnn nt ni4wds 5a,tuo edhSuo pci uppf o ddmoanAmopvvOea a. ynIppAooeras sh oiyl neysnh ,dlZ64eploru l5a tain eboPfu ileae do po obdrvpd pns0 e aeoalss smbiv,uoacithroped ulonsm trwunce doogtdagstneatt w,Zt

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

2 thoughts on “FDA approves Lilly’s Zepbound for obstructive sleep apnea

  1. Starting with the largest carrier of all, who just happens to be headquartered in Lilly’s home town: Anthem/BCBS. Medicaid is covering it in many states but not Anthem.

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In